Mumbai, Aug. 26 -- The renewed agreement carries an expanded product portfolio, an extended tenure and a higher contract value of AUD 30 million (approximately Rs 204 crore) over a three-year period, effective immediately. The agreement translates to about AUD 10 million of contracted supply annually and provides for further growth through new product development and line extensions during its term.

Noumed will continue to manage the full value chain - manufacturing, product sourcing, regulatory compliance, TGA registrations, warehousing, quality assurance and nationwide distribution - entrusted to a single accountable partner. Noumed owns the product registrations and holds the marketing authorization, while the pharmacy chain retails t...